DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel

Biophysical Journal

Volumn 95, Issue 10, 2008, Pages 4689-4697

  Koster, Joseph C ^a   Kurata, Harley T ^a   Enkvetchakul, Decha ^a   Nichols, Colin G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

ANIMAL; ARTICLE; CELL MEMBRANE POTENTIAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; KATP CHANNELS; MEMBRANE POTENTIALS; MUTAGENESIS, SITE-DIRECTED; POTASSIUM CHANNELS, INWARDLY RECTIFYING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 58149288315     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.108.138685     Document Type: Article

References (43)

1. Koster, J. C., B. A. Marshall, N. Ensor, J. A. Corbett, and C. G. Nichols. 2000. Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell. 100:645-654.
2. Koster, J. C., M. S. Remedi, R. Masia, B. L. Patton, A. Tong, and C. G. Nichols. 2006. Expression of ATP-insensitive KATP channels in pancreatic β-cells underlies a spectrum of diabetic phenotypes. Diabetes. 55:2957-2964.
3. Tarasov, A. I., H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft. 2006. A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells. Diabetes. 55:3075-3082.
4. Mlynarski, W., A. I. Tarasov, A. Gach, C. A. Girard, I. Pietrzak, L. Zubcevic, J. Kusmierek, T. Klupa, M. T. Malecki, and F. M. Ashcroft. 2007. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat. Clin. Pract. Neurol. 3:640-645.
5. Bahi-Buisson, N., M. Eisermann, S. Nivot, C. Bellanne-Chantelot, O. Dulac, N. Bach, P. Plouin, C. Chiron, and P. de Lonlay. 2007. Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2. J. Child Neurol. 22:1147-1150.
6. Shimomura, K., F. Horster, H. D. Wet, S. E. Flanagan, S. Ellard, A. T. Hattersley, N. I. Wolf, F. Ashcroft, and F. Ebinger. 2007. A novel mutation causing DEND syndrome. Neurology. 69:1342-1349.
7. Yamada, K., J. J. Ji, H. Yuan, T. Miki, S. Sato, N. Horimoto, T. Shimizu, S. Seino, and N. Inagaki. 2001. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science. 292:1543-1546.
8. Ma, W., J. Berg, and G. Yellen. 2007. Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci. 27:3618-3625.
9. Gloyn, A. L., E. R. Pearson, J. F. Antcliff, P. Proks, G. J. Bruining, A. S. Slingerland, N. Howard, S. Srinivasan, J. M. Silva, J. Molnes, E. L. Edghill, T. M. Frayling, I. K. Temple, D. Mackay, J. P. Shield, Z. Sumnik, A. van Rhijn, J. K. Wales, P. Clark, S. Gorman, J. Aisenberg, S. Ellard, P. R. Njolstad, F. M. Ashcroft, and A. T. Hattersley. 2004. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350:1838-1849.
10. Koster, J. C., A. Permutt, and C. G. Nichols. 2005. Diabetes and insulin secretion: the KATP connection. Diabetes. 54:3065-3072.
11. Hattersley, A. T., and F. M. Ashcroft. 2005. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 54:2503-2513.
12. Slingerland, A. S., and A. T. Hattersley. 2005. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann. Med. 37:186-195.
13. Pearson, E. R., I. Flechtner, P. R. Njolstad, M. T. Malecki, S. E. Flanagan, B. Larkin, F. M. Ashcroft, I. Klimes, E. Codner, V. Iotova, A. S. Slingerland, J. Shield, J. J. Robert, J. J. Holst, P. M. Clark, S. Ellard, O. Sovik, M. Polak, and A. T. Hattersley. 2006. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N. Engl. J. Med. 355:467-477.
14. Koster, J. C., F. Cadario, C. Peruzzi, C. Colombo, C. G. Nichols, and F. Barbetti. 2007. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J. Clin. Endocrinol. Metab. 93:1054-1061.
15. Antcliff, J. F., S. Haider, P. Proks, M. S. Sansom, and F. M. Ashcroft. 2005. Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J. 24:229-239.
16. Enkvetchakul, D., and C. G. Nichols. 2003. Gating mechanism of KATP channels: function fits form. J. Gen. Physiol. 122:471-480.
17. Flanagan, S. E., E. L. Edghill, A. L. Gloyn, S. Ellard, and A. T. Hattersley. 2006. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia. 49:1190-1197.
18. Vaxillaire, M., C. Populaire, K. Busiah, H. Cave, A. L. Gloyn, A. T. Hattersley, P. Czernichow, P. Froguel, and M. Polak. 2004. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes. 53:2719-2722.
19. Massa, O., D. Iafusco, E. D'Amato, A. L. Gloyn, A. T. Hattersley, B. Pasquino, G. Tonini, F. Dammacco, G. Zanette, F. Meschi, O. Porzio, G. Bottazzo, A. Crino, R. Lorini, F. Cerutti, M. Vanelli, and F. Barbetti. 2005. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum. Mutat. 25:22-27.
20. + channels in neonatal diabetes: implications for pharmacogenomic therapy. Diabetes. 54:2645-2654.
21. Proks, P., J. F. Antcliff, J. Lippiat, A. L. Gloyn, A. T. Hattersley, and F. M. Ashcroft. 2004. Molecular basis of Kir6.2 mutations associated with neonatal diabetes plus neurological features. Proc. Natl. Acad. Sci. USA. 101:17539-17544.
22. Proks, P., C. Girard, and F. M. Ashcroft. 2005. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP. Hum. Mol. Genet. 14:2717-2726.
23. Gloyn, A. L., F. Reimann, C. Girard, E. L. Edghill, P. Proks, E. R. Pearson, I. K. Temple, D. J. Mackay, J. P. Shield, D. Freedenberg, K. Noyes, S. Ellard, F. M. Ashcroft, F. M. Gribble, and A. T. Hattersley. 2005. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum. Mol. Genet. 14:925-934.
24. Girard, C. A., K. Shimomura, P. Proks, N. Absalom, L. Castano, D. N. Perez, and F. M. Ashcroft. 2006. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes. Pflugers Arch. 453:323-332.
25. Shyng, S., T. Ferrigni, and C. G. Nichols. 1997. Control of rectification and gating of cloned KATP channels by the Kir6.2 subunit. J. Gen. Physiol. 110:141-153.
26. Enkvetchakul, D., G. Loussouarn, E. Makhina, S. L. Shyng, and C. G. Nichols. 2000. The kinetic and physical basis of K(ATP) channel gating: toward a unified molecular understanding. Biophys. J. 78:2334-2348.
27. Inagaki, N., T. Gonoi, J. P. T. Clement, N. Namba, J. Inazawa, G. Gonzalez, L. Aguilar-Bryan, S. Seino, and J. Bryan. 1995. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 270:1166-1170.
28. Aguilar-Bryan, L., C. G. Nichols, S. W. Wechsler, J. P. T. Clement, A. E. R. Boyd, G. Gonzalez, H. Herrera-Sosa, K. Nguy, J. Bryan, and D. A. Nelson. 1995. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 268:423-426.
29. Sigworth, F. J. 1980. The variance of sodium current fluctuations at the node of Ranvier. J. Physiol. 307:97-129.
30. Neher, E., and C. F. Stevens. 1977. Conductance fluctuations and ionic pores in membranes. Annu. Rev. Biophys. Bioeng. 6:345-381.
31. Li, L., X. Geng, and P. Drain. 2002. Open state destabilization by ATP occupancy is mechanism speeding burst exit underlying KATP channel inhibition by ATP. J. Gen. Physiol. 119:105-116.
32. Trapp, S., P. Proks, S. J. Tucker, and F. M. Ashcroft. 1998. Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J. Gen. Physiol. 112:333-349.
33. Enkvetchakul, D., I. Jeliazkova, J. Bhattacharyya, and C. G. Nichols. 2007. Control of inward rectifier K channel activity by lipid tethering of cytoplasmic domains. J. Gen. Physiol. 130:329-334.
34. Shimomura, K., C. A. Girard, P. Proks, J. Nazim, J. D. Lippiat, F. Cerutti, R. Lorini, S. Ellard, A. T. Hattersely, F. Barbetti, and F. M. Ashcroft. 2006. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes. 55:1705-1712.
35. Cukras, C. A., I. Jeliazkova, and C. G. Nichols. 2002. The role of NH(2)-terminal positive charges in the activity of inward rectifier K(ATP) channels. J. Gen. Physiol. 120:437-446.
36. Bhattacharyya, J., D. Enkvetchakul, D. Nelson, K. Markova, C. Cukras, I. Jeliazkova, and C. G. Nichols. 2003. Cloning and expression of bacterial Kirs. Biophys. J. 84:78a. (Abstr.)
37. Gopalakrishnan, K., G. Sowmiya, S. S. Sheik, and K. Sekar. 2007. Ramachandran plot on the web (2.0). Protein Pept. Lett. 14:669-671.
38. 2-binding site on Kir6.2 by molecular modelling and functional analysis. EMBO J. 26: 3749-3759.
39. 2 site in the N terminus. J. Biol. Chem. 278:10500-10505.
40. MacGregor, G. G., K. Dong, C. G. Vanoye, L. Tang, G. Giebisch, and S. C. Hebert. 2002. Nucleotides and phospholipids compete for binding to the C terminus of KATP channels. Proc. Natl. Acad. Sci. USA. 99:2726-2731.
41. Cukras, C. A., I. Jeliazkova, and C. G. Nichols. 2002. Structural and functional determinants of conserved lipid interaction domains of inward rectifying Kir6.2 channels. J. Gen. Physiol. 119:581-591.
42. 2): interaction with other regulatory ligands. Prog. Biophys. Mol. Biol. 94:320-335.
43. Nichols, C. G. 2006. KATP channels as molecular sensors of cellular metabolism. Nature. 440:470-476.